Neurofibromatosis 2

Also known as: Neurofibromatosis, type 2 (acoustic neurofibromatosis) / Neurofibromatosis Type 2 / Neurofibromatosis Type II / NF2 / Neurofibromatosis, type 2 / Neurofibromatosis, type 2 (disorder) / Neurofibromatosis, unspecified / Neurofibromatoses / Neurofibromatosis / Neurofibromatosis (morphologic abnormality) / Neurofibromatosis syndrome (disorder)

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB12707AR-420Terminated1
DB01590Everolimus0Completed1
DB01259Lapatinib0Completed1
DB00112Bevacizumab1Active Not Recruiting1
DB00002Cetuximab1Active Not Recruiting1
DB14123Menthol1Active Not Recruiting1
DB00877Sirolimus1Active Not Recruiting1
DB06287Temsirolimus1Active Not Recruiting1
DB00313Valproic acid1Active Not Recruiting1
DB00254Doxycycline1 / 2Recruiting1
DB00945Acetylsalicylic acid2Recruiting1
DB06626Axitinib2Completed1
DB00112Bevacizumab2Completed3
DB12267Brigatinib2Recruiting1
DB08865Crizotinib2Active Not Recruiting1
DB06423Endostatin2Completed1
DB01590Everolimus2Completed2
DB01590Everolimus2Terminated1
DB11737Icotinib2Completed1
DB01259Lapatinib2Completed1
DB11828Neratinib2Recruiting1
DB05173PTC2992Terminated1
DB11689Selumetinib2Active Not Recruiting1
DB11925Vistusertib2Completed1
DB12707AR-422 / 3Recruiting1
DB00112BevacizumabNot AvailableRecruiting1
DB14907Bevacizumab zirconium Zr-89Not AvailableRecruiting1